Skip to main content
SpringerLink
Log in

Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-Fluorouracil

  • Letters To The Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Schabel Jr FM, Trader MW, Laster Jr WR, Corbett TH, Griswold Jr DP (1979) Cis-dichlorodiammineplatinum (II): combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Rep 63: 1459–1473

    Google Scholar 

  2. Dionet C, Verrelle C (1984) Curability of mouse L1210 leukemia by combination of 5-fluorouracil, cis-diamminedichloro-platinum(II), and low doses of gamma rays. Cancer Res 44: 652–656

    Google Scholar 

  3. Beaupain R, Dionet C (1985) Effects of combined treatments of cis-diamminedichloroplatinum(II), 5-fluorouracil, and x-rays on growth of human cancer nodules maintained in continuous organotypic culture. Cancer Res 45: 3150–3154

    Google Scholar 

  4. Rooney M, Kish J, Jacobs J, Kinzie J, Weaver A, Crissman J, AlSarraf M (1985) Improved complete response rate and survival in advanced head and neck cancer after three course induction therapy with 120 hours 5-fluorouracil infusion and cisplatin. Cancer 55: 1123–1128

    Google Scholar 

  5. Dy C, Gil A, Algarra SM, Aparicio LA, Calvo F, Herranz P (1986) Combination chemotherapy of cisplatin and 5-FU in advanced colorectal carcinoma. Cancer Treat Rep 70: 465–468

    Google Scholar 

  6. Posner MR, Belliveau JF, Weitberg AB, Sabbath K, Wiemann MC, Cummings FJ, Calabresi P (1987) Continuous-infusion cisplatin and bolus 5-fluorouracil in colorectal carcinoma. Cancer Treat Rep 71: 975–977

    Google Scholar 

  7. Forastiere AA, Belliveau JF, Goren M, Vogel WC, Posner MC, O'Leary GP (1988) Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittant bolus cis-diamminedichloroplatinum (II) in head and neck cancer patients. Cancer Res 48: 3869–3874

    Google Scholar 

  8. Miller AA, Moore EC, Hurlbert RB, Benvenuto JA, Loo TL (1983) Pharmacological and biochemical interactions of N-(phosphonacetyl)-L-aspartate and 5 fluorouracil in beagles. Cancer Res 43: 2565–2570

    Google Scholar 

  9. MacMillan WE, Wolberg WH, Welling PG (1978) Pharmacokinetics of fluorouracil in humans. Cancer Res 38: 3479–3482

    Google Scholar 

  10. Cohen JL, Irwin LE, Marshall GJ, Darvey H, Bateman JR (1974) Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893). Cancer Chemother Rep 58: 723–731

    Google Scholar 

  11. Heggie GD, Sommadossi JP, Cross DS, Huster WJ, Diasio RB (1987) Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine and bile. Cancer Res 47: 2203–2206

    Google Scholar 

  12. Belliveau JF, Posner MR, Ferrari L, Crabtree GW, Cummings FJ, Wiemann MC, O'Leary Jr GP, Griffin H, Phaneuf MA, O'Rourke A, Calabresi P (1986) Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion. Cancer Treat Rep 70: 1215–1217

    Google Scholar 

  13. Reece PA, Stafford I, Russell J, Gill PG (1986) Reduced ability to clear ultrafilterable platinum with repeated courses of cis-platin. J Clin Oncol 4: 1392–1398

    Google Scholar 

  14. Farris FF, King FG, Dedrick RL, Litterst CL (1985) Physiological model for the pharmacokinetics of cis-dichlorodiammine-platinum(II) (DDP) in the tumored rat. J Pharmacokin Biopharm 13: 13–40

    Google Scholar 

  15. King FG, Dedrick RL, Farris FF (1986) Physiological pharmacokinetic modeling of cis-dichlorodiammineplatinum(II) (DDP) in several species. J Pharmacokin Biopharm 14: 131–154

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Biology and Chemistry, Providence College, 02918, Providence, RI, USA

    J. F. Belliveau, G. P. O'Leary Jr. & E. Ingersoll

  2. Department of Medicine, Division of Hematology/Oncology, Roger Williams Cancer Center Brown University, 02908, Providence, RI, USA

    J. F. Belliveau, M. R. Posner, G. W. Crabtree, A. B. Weitberg, M. C. Wiemann, F. J. Cummings & P. Calabresi

Authors
  1. J. F. Belliveau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. R. Posner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. W. Crabtree
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. B. Weitberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. C. Wiemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. J. Cummings
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. P. O'Leary Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E. Ingersoll
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. Calabresi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Belliveau, J.F., Posner, M.R., Crabtree, G.W. et al. Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-Fluorouracil. Eur J Clin Pharmacol 40, 115–117 (1991). https://doi.org/10.1007/BF00315150

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00315150

Key words

Search

Navigation